Literature DB >> 24990353

Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature.

Kiranpreet Khosa1, Kofi Clarke.   

Abstract

INTRODUCTION: Management of ulcerative colitis (UC) pre- and post-liver transplant for primary sclerosing cholangitis (PSC) can be challenging and complex. There are no formal guidelines, but there is a plethora of data regarding the use of medical and surgical treatment options, mainly from case series, retrospective data, and experience from transplant centers. DISCUSSION: We present two cases of UC-PSC with variable severity of liver disease and discuss the available data on the management of UC pre- and post-liver transplant. A PubMed search was conducted using various keyword combinations looking for studies involving patients with UC-PSC pre- and post-liver transplant. We reviewed and summarized the available literature on the course of UC in patients with PSC-related cirrhosis pre- and post-transplant and risk of colorectal neoplasia post-transplant. Finally, we summarize the available data on the medical and surgical management of UC pre- and post-liver transplant and the effect of transplant on pouchitis. Current literature supports the use of medical therapies, including immunomodulators and biologic agents, following liver transplant. There is also literature supporting surgical management including total colectomy. A multidisciplinary, patient-centered approach is important when managing UC pre- and post-liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990353     DOI: 10.1007/s00384-014-1945-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  52 in total

Review 1.  Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.

Authors:  Antony Pan; Martin Schlup; Ralf Lubcke; Michael Schultz
Journal:  J Crohns Colitis       Date:  2011-05-18       Impact factor: 9.071

2.  Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience.

Authors:  F Gelley; P Miheller; A Péter; G Telkes; B Nemes
Journal:  Transplant Proc       Date:  2012-09       Impact factor: 1.066

3.  Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Igor Dvorchik; Michael Subotin; A Jake Demetris; John J Fung; Thomas E Starzl; Samuel Wieand; Kareem M Abu-Elmagd
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

4.  The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.

Authors:  A Sandhu; T Alameel; C H Dale; M Levstik; N Chande
Journal:  Aliment Pharmacol Ther       Date:  2012-05-23       Impact factor: 8.171

5.  The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.

Authors:  Karli J Moncrief; Anamaria Savu; Mang M Ma; Vince G Bain; Winnie W Wong; Puneeta Tandon
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

6.  Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.

Authors:  Ibrahim A Hanouneh; Carole Macaron; Rocio Lopez; Nizar N Zein; Bret A Lashner
Journal:  Inflamm Bowel Dis       Date:  2011-03-18       Impact factor: 5.325

7.  Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.

Authors:  Lisa S Poritz; Walter A Koltun
Journal:  Dis Colon Rectum       Date:  2003-02       Impact factor: 4.585

8.  Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis.

Authors:  A H Kartheuser; R R Dozois; R H Wiesner; N F LaRusso; D M Ilstrup; C D Schleck
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

9.  Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

Authors:  Kristin Kaasen Jørgensen; Lina Lindström; Milada Cvancarova; Tom H Karlsen; Maria Castedal; Styrbjörn Friman; Erik Schrumpf; Aksel Foss; Helena Isoniemi; Arno Nordin; Kathrine Holte; Allan Rasmussen; Annika Bergquist; Morten H Vatn; Kirsten Muri Boberg
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-16       Impact factor: 11.382

Review 10.  Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation.

Authors:  S J Knechtle; A M D'Alessandro; B A Harms; J D Pirsch; F O Belzer; M Kalayoglu
Journal:  Surgery       Date:  1995-10       Impact factor: 3.982

View more
  1 in total

Review 1.  Inflammatory bowel disease in liver transplanted patients.

Authors:  Tajana Filipec Kanizaj; Maja Mijic
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.